Primary intraocular lymphoma: Clinical features, diagnosis, and treatment

Clinical Lymphoma

Volumn 4, Issue 1, 2003, Pages 30-31

  Chan, Chi Chao ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ARTICLE; CLINICAL FEATURE; CYTOLOGY; DRUG MEGADOSE; EYE TOXICITY; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOGLOBULIN GENE; NONHODGKIN LYMPHOMA; PATHOGENESIS; PATHOLOGY; PRIMARY INTRAOCULAR LYMPHOMA; SLIT LAMP; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION; VITRECTOMY;

EID: 0038692112     PISSN: 15269655     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-9655(11)70005-7     Document Type: Note

References (16)

1. Buggage RR, Chan CC, Nussenblatt RB. Ocular manifestations of central nervous system lymphoma. Curr Opin Oncol 2001; 13:137-142.
2. Chan CC, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr Opin Ophthalmol 2002; 13:411-418.
3. Gill MK, Jampol LM. Variations in the presentation of primary intraocular lymphoma: case reports and a review. Surv Ophthalmol 2001; 45:463-471.
4. Read RW, Zamir E, Rao NA. Neoplastic masquerade syndromes. Surv Ophthalmol 2002; 47:81-124.
5. Rothova A, Ooijman F, Kerkhoff F, et al. Uveitis masquerade syndromes. Ophthalmology 2001; 108:386-399.
6. Tuaillon N, Chan CC. Molecular analysis of primary central nervous system and primary intraocular lymphoma. Curr Mol Med 2001; 1:259-272.
7. Hormigo A, DeAngelis LM. Primary intraocular lymphoma: clinical features, diagnosis and treatment. Clin Lymphoma 2003; 4:22-29.
8. Eby NL, Grufferman S, Flannelly CM, et al. Increasing incidence of primary brain lymphoma in the US. Cancer 1988; 62:2461-2465.
9. Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology 1993; 100:1399-1406.
10. Peterson K, Gordon KB, Heinemann MH, et al. The clinical spectrum of ocular lymphoma. Cancer 1993; 72:843-849.
11. Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology 2003. In press.
12. Wolf LA, Reed GF, Buggage RR, et al. Levels of IL-10 and IL-6 in the vitreous are helpful for differential diagnosis of primary intraocular lymphoma and ocular inflammation. Ophthalmology 2003 (In press).
13. Barth TF, Bentz M, Dohner H, Moller P. Molecular aspects of B-cell lymphomas of the gastrointestinal tract. Clin Lymphoma 2001; 2:57-64.
14. Plotkin SR, Batchelor TT. Advances in the therapy of primary central nervous system lymphoma. Clin Lymphoma 2001; 1:263-275.
15. Batchelor TT, Kolak G, Ciordia R, et al. High-dose methotrexate for intraocular lymphoma. Clin Cancer Res 2003; 9:711-715.
16. Soussain C, Suzan F, Hoang-Xuan K, et al. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 2001; 19:742-749.